SeqLL, LLC announced today that it has been awarded a Phase I SBIR grant in the amount of $223,465 by the NIH/National Human Genome Research Institute to advance the development of Direct RNA Sequencing (DRS™) technology on SeqLL’s True Single ...
Read More »iGenomX Presents Long Single-Molecule Assembly Technology
At the recent 2016 American Society of Human Genetics (ASHG) Annual Meeting in Vancouver, iGenomX presented the first results of their long single-molecule assembly (SMA) technology. When combined with the RainDance picoliter droplet technology and Illumina’s next-generation sequencing (NGS) systems, ...
Read More »SeqLL Launches Early Access Program for New true Single Molecule Sequencing (tSMS™) Benchtop System
WOBURN, Mass.–(BUSINESS WIRE)–SeqLL, LLC today announced the launch of the tSMS System Early Access Program giving researchers priority access to its proprietary quantitative sequencing platform. This benchtop system has been designed to deliver unparalleled quantitative RNA and specialty DNA sequencing ...
Read More »SeqLL Closes Series-A Funding Round for Expansion of Single Molecule Sequencing
SeqLL Inc. raises $1M to expand and improve true Single Molecule Sequencing capabilities with a Series A round led by Genomic Diagnostic Technologies, Inc. Woburn, MA (PRWEB) SeqLL Inc., the owner of the True Single Molecule Sequencing (tSMS™) technology, announced ...
Read More »